Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by consultant99on Mar 05, 2019 3:27pm

242 Views

Post# 29445528

Warrants

Shares outstanding now at 140,042,042 as of March 4th.

1,069,300 warrants have been exercised between Feb 1st and March 4th

750,000 warrants exercised between Feb 26 and March 4th

Funding by warrant redeemption is looking better...

The intial technical target range of 0.61 to 0.66 is close at hand with lots of positive PRs expected in the next quarter. A positive scan for patient #6 would be huge; one clean scan could be an outlier but two - much less likely.

The second technical target of $1.05 to $1.15 seems much more reasonable now that we are approaching 5 year highs - its been a long time to get back to these levels.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments